Patent · US Active

COMT inhibiting methods and compositions

US10934283B2 · kind B2 · utility

0Cited by

1References

71Claims

0Family size

Assignee

Lieber Institute, Inc. · US

Inventors

James C. Barrow · Harleysville, US
Glen Ernst · Bear, US
Dominique Swinnen · Braine-l'Alleud, BE
Florian Montel · Meitingen, DE
Sabine Defays · Brussels, BE
Yifang Huang · Cheltenham, US
Pablo de Leon · Philadelphia, US
Michael S. Poslusney · Nashville, US

Key dates

Filing date	Nov 25, 2016
Grant date	Mar 2, 2021
Priority date	—
Expiry date	Nov 25, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds that inhibit COMT enzyme and pharmaceutical compositions comprising the same are provided herein. Methods of treating various psychiatric and neurological disorders with the compounds and pharmaceutical compositions described herein are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.